MNAT1 and osteosarcoma: While the expression patterns, functional significance, and underlying mechanisms of MNAT1 remain entirely unexplored in OSCC, it has been demonstrated to promote proliferation and cisplatin resistance in osteosarcoma by modulating the PI3K/Akt/mTOR pathway (26).